Verastem (VSTM) Current Leases (2019 - 2026)
Verastem (VSTM) posted quarterly Current Leases of $494000.0 for Q1 2026, down 51.52% year-over-year from $1.0 million in Q1 2025, and down 7.66% quarter-over-quarter from $535000.0 in Q4 2025.
Analysis
Verastem (VSTM) Current Leases (2019 - 2026) Analysis & Trends
Verastem's Current Leases history runs 8 years deep, the most recent figure standing at $494000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 51.52% year-over-year to $494000.0; the TTM figure through Mar 2026 stood at $494000.0 (down 51.52% YoY), while the FY2025 annual figure was $535000.0, down 46.23% from the prior year.
- Current Leases for Q1 2026 stood at $494000.0, down from $535000.0 in the prior quarter.
- The five-year high for Current Leases was $1.0 million in Q2 2025, with the low at $494000.0 in Q1 2026.
- The 5-year median for Current Leases is $829000.0 (2023), against an average of $834058.8.
- The sharpest annual moves came in 2022 and 2026: Current Leases advanced 19.38% in 2022, then sank 51.52% in 2026.
- Verastem's Current Leases stood at $794000.0 in 2022, then grew by 18.51% to $941000.0 in 2023, then rose by 5.74% to $995000.0 in 2024, then tumbled by 46.23% to $535000.0 in 2025, then declined by 7.66% to $494000.0 in 2026.
- Business Quant data shows VSTM's Current Leases at $494000.0 in Q1 2026, $535000.0 in Q4 2025, and $793000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | 493,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 493,000.00 |
| Mar 31, 2026 | 494,000.00 |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 793,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 995,000.00 |
| Sep 30, 2024 | 780,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 981,000.00 |
| Dec 31, 2023 | 941,000.00 |
| Sep 30, 2023 | 902,000.00 |
| Jun 30, 2023 | 865,000.00 |
| Mar 31, 2023 | 829,000.00 |
| Dec 31, 2022 | 794,000.00 |
| Sep 30, 2022 | 761,000.00 |
| Jun 30, 2022 | 728,000.00 |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 667,000.00 |
| Sep 30, 2021 | 638,000.00 |